Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. (Q46006772)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. |
scientific article |
Statements
Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial. (English)
Bernard Escudier
1 reference
Cezary Szczylik
Tomasz Demkow
Tim Eisen
Walter M Stadler
Stéphane Oudard
Michael Staehler
Sylvie Negrier
Christine Chevreau
Apurva A Desai
Thomas E Hutson
Martin Gore
Sibyl Anderson
Gloria Hofilena
Minghua Shan
Carol Pena
Chetan Lathia
Ronald M Bukowski
18 May 2009
27
20
3312-3318